Skip to main content
NVDA0.00%AAPL-0.04%GOOGL-3.15%MSFT0.00%AMZN+0.10%TSM-4.52%SPCX-9.14%META-0.52%AVGO-4.31%TSLA-0.38%LLY+2.83%BRK-B+1.50%MU-1.05%WMT+2.82%SKHY-8.07%JPM+0.40%AMD-8.10%V+1.59%XOM+0.08%JNJ+3.81%ASMLa-4.74%MA+1.70%ABBV+0.03%INTC-8.04%COST+1.99%CVX-0.04%0700.HK-2.89%1398.HK-1.34%CSCO-2.21%KO+2.87%PG+5.58%UNH+1.91%ORCL-2.80%BAC+0.59%1816.HK-0.22%3988.HK-1.80%HD+4.33%CAT-4.89%0005.HK-1.23%PM+2.17%HSBA.L-2.45%0857.HK-0.82%GE-0.79%AP2d-6.79%1288.HK-0.30%0939.HK-0.61%AMAT-8.16%NVS+1.52%MS-1.63%DELL-6.78%PLNJPY-1.46%EURAUD-1.28%EURCAD-1.15%AUDUSD+1.06%EURJPY-0.96%USDCAD-0.91%USDTHB+0.86%SGDJPY-0.84%GBPZAR+0.78%USDJPY-0.77%USDZAR+0.77%EURNZD-0.75%EURGBP-0.75%CHFSEK+0.73%AUDCHF+0.64%USDPLN+0.64%EURCHF-0.62%EURZAR+0.58%NZDUSD+0.54%NOKJPY-0.54%GBPAUD-0.53%GBPUSD+0.53%AUDNZD+0.52%CADCHF+0.52%EURNOK-0.48%CHFSGD+0.46%EURPLN+0.45%AUDNOK-0.43%GBPCAD-0.42%GBPTRY+0.41%USDCHF-0.41%NZDCAD-0.39%CHFJPY-0.38%AUDJPY+0.33%NZDSGD-0.32%GBPHKD+0.32%EURHKD-0.31%USDNOK-0.30%GBPMXN-0.28%USDSEK+0.27%NZDJPY-0.24%GBPJPY-0.24%EURUSD-0.22%USDTRY+0.20%USDCNH-0.20%EURCNH-0.19%USDMXN+0.18%CADJPY+0.18%EURSGD-0.17%USDDKK+0.17%USDILS+0.16%NZDMXN-0.15%CHFNOK+0.15%USDHKD-0.15%AUDCAD+0.14%AUDSGD-0.13%NZDCHF+0.12%GBPCHF+0.11%EURSEK+0.10%EURCZK+0.05%AUDDKK+0.04%USDCOP-0.04%GBPNZD-0.03%GBPSGD+0.02%EURDKK-0.01%USDSGD0.00%GAGUSD-5.89%XAGUSD-5.89%XPTUSD-4.00%GAUUSD-2.84%XAUUSD-2.84%HG1-2.70%UKOIL+2.43%USOIL+1.35%SUGAR0.00%XNGUSD0.00%COFFEE0.00%COCOA0.00%BTCUSD-3.35%ETHUSD+16.36%USDTUSD-0.02%XRPUSD+9.91%SOLUSD+10.75%TRXUSDT-0.75%ZECUSDT-7.95%DOGEUSD+14.39%XMRUSDT-1.77%LINKUSD+14.52%XLMUSD-4.59%BCHUSDT-4.51%LTCUSD+8.69%UNIUSD-6.06%SUIUSD-5.62%HBARUSDT-6.18%TONUSD+26.39%TAOUSDT-5.75%AAVEUSD-5.52%DOTUSDT-3.05%ICPUSDT-6.22%WLDUSDT-7.21%ONDOUSDT-7.19%ARBUSDT-4.79%JUPUSDT-5.17%ATOMUSDT-3.26%INJUSDT-8.12%STXUSDT-11.12%TIAUSDT-6.23%FETUSDT-6.08%PYTHUSDT-7.51%SEIUSDT-9.27%IMXUSDT-7.91%GRTUSDT-6.54%OPUSDT-8.75%WIFUSDT-6.99%IOTAUSDT-5.48%AXSUSDT-5.93%POLUSDT-4.92%FARTCOINUSDT-5.87%EOSUSDT-2.04%DYDXUSDT-6.41%GALAUSDT-5.09%ORDIUSDT-3.33%RONINUSDT-5.30%NOTUSDT-4.94%NVDA0.00%AAPL-0.04%GOOGL-3.15%MSFT0.00%AMZN+0.10%TSM-4.52%SPCX-9.14%META-0.52%AVGO-4.31%TSLA-0.38%LLY+2.83%BRK-B+1.50%MU-1.05%WMT+2.82%SKHY-8.07%JPM+0.40%AMD-8.10%V+1.59%XOM+0.08%JNJ+3.81%ASMLa-4.74%MA+1.70%ABBV+0.03%INTC-8.04%COST+1.99%CVX-0.04%0700.HK-2.89%1398.HK-1.34%CSCO-2.21%KO+2.87%PG+5.58%UNH+1.91%ORCL-2.80%BAC+0.59%1816.HK-0.22%3988.HK-1.80%HD+4.33%CAT-4.89%0005.HK-1.23%PM+2.17%HSBA.L-2.45%0857.HK-0.82%GE-0.79%AP2d-6.79%1288.HK-0.30%0939.HK-0.61%AMAT-8.16%NVS+1.52%MS-1.63%DELL-6.78%PLNJPY-1.46%EURAUD-1.28%EURCAD-1.15%AUDUSD+1.06%EURJPY-0.96%USDCAD-0.91%USDTHB+0.86%SGDJPY-0.84%GBPZAR+0.78%USDJPY-0.77%USDZAR+0.77%EURNZD-0.75%EURGBP-0.75%CHFSEK+0.73%AUDCHF+0.64%USDPLN+0.64%EURCHF-0.62%EURZAR+0.58%NZDUSD+0.54%NOKJPY-0.54%GBPAUD-0.53%GBPUSD+0.53%AUDNZD+0.52%CADCHF+0.52%EURNOK-0.48%CHFSGD+0.46%EURPLN+0.45%AUDNOK-0.43%GBPCAD-0.42%GBPTRY+0.41%USDCHF-0.41%NZDCAD-0.39%CHFJPY-0.38%AUDJPY+0.33%NZDSGD-0.32%GBPHKD+0.32%EURHKD-0.31%USDNOK-0.30%GBPMXN-0.28%USDSEK+0.27%NZDJPY-0.24%GBPJPY-0.24%EURUSD-0.22%USDTRY+0.20%USDCNH-0.20%EURCNH-0.19%USDMXN+0.18%CADJPY+0.18%EURSGD-0.17%USDDKK+0.17%USDILS+0.16%NZDMXN-0.15%CHFNOK+0.15%USDHKD-0.15%AUDCAD+0.14%AUDSGD-0.13%NZDCHF+0.12%GBPCHF+0.11%EURSEK+0.10%EURCZK+0.05%AUDDKK+0.04%USDCOP-0.04%GBPNZD-0.03%GBPSGD+0.02%EURDKK-0.01%USDSGD0.00%GAGUSD-5.89%XAGUSD-5.89%XPTUSD-4.00%GAUUSD-2.84%XAUUSD-2.84%HG1-2.70%UKOIL+2.43%USOIL+1.35%SUGAR0.00%XNGUSD0.00%COFFEE0.00%COCOA0.00%BTCUSD-3.35%ETHUSD+16.36%USDTUSD-0.02%XRPUSD+9.91%SOLUSD+10.75%TRXUSDT-0.75%ZECUSDT-7.95%DOGEUSD+14.39%XMRUSDT-1.77%LINKUSD+14.52%XLMUSD-4.59%BCHUSDT-4.51%LTCUSD+8.69%UNIUSD-6.06%SUIUSD-5.62%HBARUSDT-6.18%TONUSD+26.39%TAOUSDT-5.75%AAVEUSD-5.52%DOTUSDT-3.05%ICPUSDT-6.22%WLDUSDT-7.21%ONDOUSDT-7.19%ARBUSDT-4.79%JUPUSDT-5.17%ATOMUSDT-3.26%INJUSDT-8.12%STXUSDT-11.12%TIAUSDT-6.23%FETUSDT-6.08%PYTHUSDT-7.51%SEIUSDT-9.27%IMXUSDT-7.91%GRTUSDT-6.54%OPUSDT-8.75%WIFUSDT-6.99%IOTAUSDT-5.48%AXSUSDT-5.93%POLUSDT-4.92%FARTCOINUSDT-5.87%EOSUSDT-2.04%DYDXUSDT-6.41%GALAUSDT-5.09%ORDIUSDT-3.33%RONINUSDT-5.30%NOTUSDT-4.94%
BL

BioAge Labs Inc. (BIOA)

NASDAQ • Healthcare

$5.53
+$0.02 (+0.4%)
Market closed

Last close at October 22, 2026 at 20:00 UTC

Open$5.45
Day Range$5.41 - $5.62
Avg. Volume (3M)861.5K
Market Cap$208.2M
52 Week Range
$4.81$25.96
Next EarningsIn 14 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$2.4M100%
Gross Profitminus cost of goods$2.4M100%

Fundamentals & Financials

Revenue (TTM)
$10.3M
Net Income (TTM)
-$94.4M
EPS (TTM)
-$2.38
ROA (TTM)
-23.8%
Current Ratio
17.19

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+13.3%Q1 2026-$0.72
+18.7%Q2 2026-$0.52
+4.5%Q3 2026-$0.58
Next

Nov 5

in 14 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +4.5%

BioAge Labs beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported Aug. 6, as revenue rose 1.6% to about $2.5 million, topping about $1.5 million of consensus by 63.7%, and EPS of -$0.58 beat the -$0.61 estimate by 4.5% while improving 3.3% from -$0.60 a year ago. Gross profit was $0, leaving gross margin near 0%, and operating loss came to about $29.3 million with operating margin around -1,197%. Net income was a loss of about $26.1 million, down 21.0% from a loss of $21.6 million a year ago, and operating cash flow was negative $43.3 million. Consensus for the next period calls for EPS of -$0.72.

View full earnings history

About BioAge Labs Inc.

BioAge Labs Inc. is a NASDAQ-listed Biotechnology company in the healthcare sector that develops therapeutic product candidates for metabolic diseases. In qualitative terms, it is a clinical-stage biotech business. BioAge Labs identifies drug targets from molecular changes associated with aging and advances those findings into medicines.

Name
BioAge Labs Inc.
CEO
Kristen Fortney
Website
bioagelabs.com
Industry
Healthcare
Year Founded
2015
Employees
61

Today's Snapshot

AI-generated

BIOA ended the day slightly higher at 5.53, while its sector was firmer. Shares changed hands at about two-thirds of its usual level. BIOA reports earnings on 5 November.

Trading Volume

Below 10d avg (758.3K)

481.7K

vs S&P 500 Today

Outperforming Market

+1.62%

Updated: October 22, 2026 at 20:23 UTC

Technical Indicators

0 Buy3 Neutral5 Sell
BIOA exhibits a decidedly bearish technical profile at about 5.53, driven by a very strong ADX near 48 that reflects a powerful trending environment and a low RSI flirting with oversold territory. The price is well below key longer-term averages, including the 200-day near the mid-teens, and OBV shows a pronounced negative volume trend that reinforces selling pressure. Volatility is elevated in percentage terms with ATR near eight percent, and short-term momentum measures remain negative. Technical takeaway: Strong Sell — strong trend strength to the downside with heavy negative volume support.
All signals
  • EMA (5 indicators)$5.60 - $13.05
    Sell
  • RSI (14)31.85
    Neutral
  • Stochastic %K (14, 3, 3)34.49
    Neutral
  • MACD Level (12, 26)-0.90
    Neutral

Peers & Related Assets

ALLOAllogene Therapeutics, Inc.
$1.25-6.0%
EDITEditas Medicine, Inc.
$2.49-0.8%
AVIRAtea Pharmaceuticals, Inc.
$4.05-0.7%
CGCCanopy Growth Corporation
$0.67-1.0%
ACBAurora Cannabis Inc.
$3.97+0.3%
HUMAHumacyte, Inc.
$0.42+1.9%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.